B Group, Inc. Portfolio Holdings

B Group, Inc.

$136 Billion
Q3 2025

B Group, Inc. has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $136 Billion distributed in 20 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $35.4B, Zai Lab LTD with a value of $13.6B, Akero Therapeutics, Inc. with a value of $11B, Cellectis S.A. with a value of $9.35B, and Taysha Gene Therapies, Inc. with a value of $5.89B.

Examining the 13F form we can see an increase of $6.01B in the current position value, from $130B to 136B.

B Group, Inc. is based out at Dallas, TX

Below you can find more details about B Group, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $136 Billion

Healthcare: $111 Billion

Technology: $14 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
ADMA Adma Biologics, Inc. Healthcare	$3.06B	$35.4 Billion 26.02% of portfolio	2,412,542	Q3 2025 Added 4.1%
ZLAB Zai Lab LTD Healthcare	$2.13B	$13.6 Billion 9.97% of portfolio	400,000	Q4 2024 New
AKRO Akero Therapeutics, Inc. Healthcare	$2.52B	$11 Billion 8.12% of portfolio	232,446	Q2 2025 Reduced 4.15%
RARE Ultragenyx Pharmaceutical Inc. Healthcare	$2.32B	$4.06 Billion 2.99% of portfolio	135,000	Q3 2025 Added 22.73%

Summary

Portfolio
No. of Stocks 20
Current Value $136 Billion
Prior Value $130 Billion
Filing
Period Q3 2025
Filing Date November 14, 2025
Form Type 13F-HR
Activity in Q3 2025
New Purchases 2 stocks
Additional Purchases 4 stocks
Sold out of 0 stocks
Reduced holdings in 3 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on B Group, Inc. with notifications on news.

Account